174 related articles for article (PubMed ID: 9085037)
1. Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents.
Imanishi T; Sawa A; Ichimaru Y; Miyashiro M; Kato S; Yamamoto T; Ueki S
Eur J Pharmacol; 1997 Mar; 321(3):273-8. PubMed ID: 9085037
[TBL] [Abstract][Full Text] [Related]
2. Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats.
Egawa T; Mishima K; Matsumoto Y; Iwasaki K; Iwasaki K; Fujiwara M
Jpn J Pharmacol; 1997 Nov; 75(3):275-81. PubMed ID: 9434259
[TBL] [Abstract][Full Text] [Related]
3. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.
Cumin R; Bandle EF; Gamzu E; Haefely WE
Psychopharmacology (Berl); 1982; 78(2):104-11. PubMed ID: 6817363
[TBL] [Abstract][Full Text] [Related]
4. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
Nagakura A; Niimura M; Takeo S
Br J Pharmacol; 2002 Apr; 135(7):1783-93. PubMed ID: 11934820
[TBL] [Abstract][Full Text] [Related]
5. Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats.
Zhang HT; O'Donnell JM
Psychopharmacology (Berl); 2000 Jun; 150(3):311-6. PubMed ID: 10923759
[TBL] [Abstract][Full Text] [Related]
6. Brain cyclic AMP and memory in mice.
Randt CT; Judge ME; Bonnet KA; Quartermain D
Pharmacol Biochem Behav; 1982 Oct; 17(4):677-80. PubMed ID: 6294676
[TBL] [Abstract][Full Text] [Related]
7. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
[TBL] [Abstract][Full Text] [Related]
8. Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on memory in the radial-arm maze and inhibitory avoidance tests in rats.
Zhang HT; Huang Y; Suvarna NU; Deng C; Crissman AM; Hopper AT; De Vivo M; Rose GM; O'Donnell JM
Psychopharmacology (Berl); 2005 May; 179(3):613-9. PubMed ID: 15672274
[TBL] [Abstract][Full Text] [Related]
9. WEB 1881 FU ameliorates impairment of working memory induced by scopolamine and cerebral ischemia in the three-panel runway task.
Ohno M; Yamamoto T; Kitajima I; Ueki S
Jpn J Pharmacol; 1990 Sep; 54(1):53-60. PubMed ID: 2273648
[TBL] [Abstract][Full Text] [Related]
10. The effects of a selective cAMP phosphodiesterase inhibitor, rolipram, on methamphetamine-induced behavior.
Iyo M; Maeda Y; Inada T; Kitao Y; Sasaki H; Fukui S
Neuropsychopharmacology; 1995 Aug; 13(1):33-9. PubMed ID: 8526969
[TBL] [Abstract][Full Text] [Related]
11. Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats.
Sakurai T; Ojima H; Yamasaki T; Kojima H; Akashi A
Jpn J Pharmacol; 1989 May; 50(1):47-53. PubMed ID: 2724699
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase type 4 that regulates cAMP level in cortical neurons shows high sensitivity to rolipram.
Yamashita N; Yamauchi M; Baba J; Sawa A
Eur J Pharmacol; 1997 Oct; 337(1):95-102. PubMed ID: 9389386
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism.
Zhang HT; Crissman AM; Dorairaj NR; Chandler LJ; O'Donnell JM
Neuropsychopharmacology; 2000 Aug; 23(2):198-204. PubMed ID: 10882846
[TBL] [Abstract][Full Text] [Related]
14. Alterations of cAMP response element-binding activity in the aged rat brain in response to administration of rolipram, a cAMP-specific phosphodiesterase inhibitor.
Asanuma M; Nishibayashi S; Iwata E; Kondo Y; Nakanishi T; Vargas MG; Ogawa N
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):210-5. PubMed ID: 8883954
[TBL] [Abstract][Full Text] [Related]
15. Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action.
Rutten K; Prickaerts J; Blokland A
Neurobiol Learn Mem; 2006 Mar; 85(2):132-8. PubMed ID: 16242977
[TBL] [Abstract][Full Text] [Related]
16. The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat.
Rutten K; Lieben C; Smits L; Blokland A
Psychopharmacology (Berl); 2007 Jun; 192(2):275-82. PubMed ID: 17265077
[TBL] [Abstract][Full Text] [Related]
17. Delayed treatment with rolipram protects against neuronal damage following global ischemia in rats.
Block F; Tondar A; Schmidt W; Schwarz M
Neuroreport; 1997 Dec; 8(17):3829-32. PubMed ID: 9427378
[TBL] [Abstract][Full Text] [Related]
18. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory.
Barad M; Bourtchouladze R; Winder DG; Golan H; Kandel E
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):15020-5. PubMed ID: 9844008
[TBL] [Abstract][Full Text] [Related]
19. Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse.
Lenègre A; Chermat R; Avril I; Stéru L; Porsolt RD
Pharmacol Biochem Behav; 1988 Mar; 29(3):625-9. PubMed ID: 3362958
[TBL] [Abstract][Full Text] [Related]
20. Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram.
Iyo M; Bi Y; Hashimoto K; Inada T; Fukui S
Eur J Pharmacol; 1996 Sep; 312(2):163-70. PubMed ID: 8894591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
